These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 22744939

  • 21. [Evaluation of hearing in children with solid tumors treated by chemotherapy].
    Gryczyńska D, Rychwalska M, Pekacka K, Krawczyński M, Bodalski J.
    Otolaryngol Pol; 2001; 55(2):179-83. PubMed ID: 11494735
    [Abstract] [Full Text] [Related]

  • 22. Recovery from cisplatin-induced ototoxicity: a case report and review.
    Truong MT, Winzelberg J, Chang KW.
    Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1631-8. PubMed ID: 17706797
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM, Feeney MP, Gates GA.
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [Abstract] [Full Text] [Related]

  • 24. Cisplatinum ototoxicity in children, long-term follow up.
    Al-Khatib T, Cohen N, Carret AS, Daniel S.
    Int J Pediatr Otorhinolaryngol; 2010 Aug; 74(8):913-9. PubMed ID: 20846503
    [Abstract] [Full Text] [Related]

  • 25. [Monitoring hearing during ototoxic cisplatin therapy].
    Kluba J, Kluba U, von Specht H, Mittler U.
    Padiatr Grenzgeb; 1990 Aug; 29(1):19-23. PubMed ID: 2342815
    [Abstract] [Full Text] [Related]

  • 26. Neurotoxicity of BFM-95 on the medial olivocochlear bundle assessed by means of contralateral suppression of 2f1-f2 distortion product otoacoustic emissions.
    Riga M, Korres S, Psarommatis I, Varvutsi M, Giotakis I, Papadas T, Ferekidis E, Apostolopoulos N.
    Otol Neurotol; 2007 Feb; 28(2):208-12. PubMed ID: 17255889
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F.
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy.
    Allen GC, Tiu C, Koike K, Ritchey AK, Kurs-Lasky M, Wax MK.
    Otolaryngol Head Neck Surg; 1998 May; 118(5):584-8. PubMed ID: 9591854
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Ototoxicity from cisplatin therapy in childhood cancer.
    Coradini PP, Cigana L, Selistre SG, Rosito LS, Brunetto AL.
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):355-60. PubMed ID: 17551394
    [Abstract] [Full Text] [Related]

  • 39. cis-platinum ototoxicity in children.
    Weatherly RA, Owens JJ, Catlin FI, Mahoney DH.
    Laryngoscope; 1991 Sep; 101(9):917-24. PubMed ID: 1886439
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.